Genesis Medical Interventional Inc.

by Anne Staylor and Mary Thompson Since the mid 1990s, expanding the therapeutic window and speeding time to blood flow restoration (recanalization) have been the driving forces for researchers, drug

While the debate continues about whether embolic protection devices are really necessary, the space continues to generate interest from investors, start-ups and large companies looking for new technol

by Anne Staylor and Mary Thompson For device developers, the market for acute ischemic stroke (AIS) has been enticing as the lack of effective treatment options coupled with the huge unmet clinical ne

Interventional Cardiology Developments in Cardiac Stenting: Comparative Studies Raise Questions Adding fuel to recent concerns about the cost effectiveness, safety, and off-label use of drug-eluting s